Inceptionr LLC Buys Shares of 2,609 MKS Inc. $MKSI

Inceptionr LLC bought a new position in shares of MKS Inc. (NASDAQ:MKSI) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,609 shares of the scientific and technical instruments company’s stock, valued at approximately $323,000.

Other institutional investors also recently modified their holdings of the company. SJS Investment Consulting Inc. acquired a new stake in shares of MKS during the 3rd quarter valued at $30,000. Smartleaf Asset Management LLC increased its holdings in MKS by 74.5% in the 3rd quarter. Smartleaf Asset Management LLC now owns 260 shares of the scientific and technical instruments company’s stock worth $32,000 after purchasing an additional 111 shares in the last quarter. Winnow Wealth LLC acquired a new position in MKS in the 3rd quarter worth about $38,000. Salomon & Ludwin LLC bought a new position in MKS in the third quarter valued at about $49,000. Finally, Abich Financial Wealth Management LLC bought a new position in MKS in the third quarter valued at about $65,000. 99.79% of the stock is currently owned by institutional investors and hedge funds.

Key MKS News

Here are the key news stories impacting MKS this week:

• Positive Sentiment: MKS announced that its near‑term science‑based emissions reduction targets were approved by the Science Based Targets initiative (SBTi), a credibility boost for the company’s ESG profile that can broaden investor interest. MKS Inc. Announces SBTi Approval of Science-Based Emissions Reduction Targets
• Positive Sentiment: Research firm Zacks issued a string of upward revisions and maintains a “Strong‑Buy” stance — raising near‑term and multi‑year EPS forecasts (multiple quarters, FY2026–FY2028). Those estimate lifts support a continued growth narrative and may underpin longer‑term upside.
• Positive Sentiment: Market commentary highlights accelerating end‑market demand tied to AI and a photonics product launch as drivers for recent share‑price gains; analysts and investors have been re‑rating the stock on that secular exposure. Assessing MKS Instruments (MKSI) Valuation After AI Demand And Photonics Launch Fuel Strong Share Price Gains
• Positive Sentiment: Investor letters and market notes point to improving end markets contributing to MKS’s momentum, reinforcing demand recovery themes that support revenue and margin outlooks. MKS (MKSI) Gained from End Markets Picking Up
• Neutral Sentiment: Amid many upward revisions, Zacks made a small downward tweak to one quarter (Q2 2027) — a minor calibration versus the broader set of raises; overall Zacks remains bullish.
• Negative Sentiment: Despite the positive newsflow, the stock is pulling back — most likely due to profit‑taking after a strong run (valuation is rich: trailing P/E ~48.9) and lingering sensitivity to quarterly beats/misses. The company slightly missed the most recent quarterly EPS consensus by $0.04, which can amplify short‑term volatility and sell‑side caution.

Insider Transactions at MKS

In other news, EVP Kathleen Flaherty Burke sold 4,254 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $250.00, for a total value of $1,063,500.00. Following the transaction, the executive vice president owned 53,794 shares in the company, valued at approximately $13,448,500. The trade was a 7.33% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO John Tseng-Chung Lee sold 30,000 shares of the company’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $256.77, for a total transaction of $7,703,100.00. Following the completion of the sale, the chief executive officer directly owned 154,696 shares in the company, valued at approximately $39,721,291.92. This represents a 16.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 68,163 shares of company stock worth $17,215,417. Company insiders own 0.57% of the company’s stock.

MKS Trading Down 4.8%

NASDAQ MKSI opened at $213.49 on Friday. The firm has a market capitalization of $14.36 billion, a PE ratio of 48.85, a price-to-earnings-growth ratio of 1.20 and a beta of 1.94. The business’s 50-day moving average price is $225.73 and its two-hundred day moving average price is $169.03. The company has a current ratio of 2.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.53. MKS Inc. has a 12 month low of $54.84 and a 12 month high of $269.91.

MKS (NASDAQ:MKSI) last issued its quarterly earnings data on Tuesday, February 17th. The scientific and technical instruments company reported $2.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.51 by ($0.04). The company had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.02 billion. MKS had a return on equity of 20.85% and a net margin of 7.53%.MKS’s revenue was up 10.5% compared to the same quarter last year. During the same quarter last year, the business earned $2.15 earnings per share. MKS has set its Q1 2026 guidance at 1.720-2.280 EPS. On average, analysts expect that MKS Inc. will post 6.94 EPS for the current year.

MKS Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 6th. Shareholders of record on Monday, February 23rd were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 0.5%. The ex-dividend date was Monday, February 23rd. This is a positive change from MKS’s previous quarterly dividend of $0.22. MKS’s dividend payout ratio (DPR) is 22.88%.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Morgan Stanley restated an “overweight” rating and set a $300.00 price target on shares of MKS in a report on Thursday, February 19th. Cantor Fitzgerald raised their price objective on shares of MKS from $200.00 to $300.00 and gave the company an “overweight” rating in a report on Tuesday, January 20th. Needham & Company LLC lifted their target price on shares of MKS from $260.00 to $300.00 and gave the stock a “buy” rating in a research report on Thursday, February 19th. TD Cowen boosted their target price on shares of MKS from $200.00 to $230.00 and gave the stock a “buy” rating in a report on Thursday, January 22nd. Finally, Mizuho set a $320.00 price target on shares of MKS in a research report on Thursday, February 19th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $273.46.

About MKS

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.